Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ushashi Banerjee

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Frontiers in Immunology|April 26, 2021
Immune Subtyping in Latent TuberculosisUshashi Banerjee, Priyanka Baloni, Amit Singh, et al.
Frontiers in Chemistry|December 31, 2020
A Multi-Pronged Computational Pipeline for Prioritizing Drug Target Strategies for Latent TuberculosisUshashi Banerjee, Santhosh Sankar, Amit Singh, et al.
HLA|May 3, 2023
Pressured cytotoxic T cell epitope strength among SARS-CoV-2 variants correlates with COVID-19 severityVishal Rao, Ushashi Banerjee, Narmada Sambaturu, et al.
Journal of Chemical Information and Modeling|September 27, 2023
PathTracer Comprehensively Identifies Hypoxia-Induced Dormancy Adaptations in <i>Mycobacterium tuberculosis</i>Ushashi Banerjee, Adithya Chedere, Raksha Padaki, et al.
Genes and Immunity|July 12, 2023
Systems-level profiling of early peripheral host-response landscape variations across COVID-19 severity states in an Indian cohortUshashi Banerjee, Sneha Chunchanur, Ambica R, et al.
Molecular Omics|August 16, 2022
A 9-gene biomarker panel identifies bacterial coinfections in culture-negative COVID-19 casesUshashi Banerjee, Pragati Rao, Megha Reddy, et al.
Immunology|March 20, 2024
Inhibition of leukotriene-B4 signalling-mediated host response to tuberculosis is a potential mode of adjunctive host-directed therapyUshashi Banerjee, Salik Miskat Borbora, Madhura Guha, et al.
Ebiomedicine|April 27, 2021
VB<sub>10</sub>, a new blood biomarker for differential diagnosis and recovery monitoring of acute viral and bacterial infectionsSathyabaarathi Ravichandran, Ushashi Banerjee, Gayathri Devi Dr, et al.
Cell Reports|April 25, 2024
The MYCN 5' UTR as a therapeutic target in neuroblastomaMarina P Volegova, Lauren E Brown, Ushashi Banerjee, et al.
Science Advances|December 13, 2023
Cysteine desulfurase (IscS)-mediated fine-tuning of bioenergetics and SUF expression prevents <i>Mycobacterium tuberculosis</i> hypervirulenceMayashree Das, Sreesa Sreedharan, Somnath Shee, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Frontiers in Immunology|April 26, 2021
Immune Subtyping in Latent TuberculosisUshashi Banerjee, Priyanka Baloni, Amit Singh, et al.
Frontiers in Chemistry|December 31, 2020
A Multi-Pronged Computational Pipeline for Prioritizing Drug Target Strategies for Latent TuberculosisUshashi Banerjee, Santhosh Sankar, Amit Singh, et al.
HLA|May 3, 2023
Pressured cytotoxic T cell epitope strength among SARS-CoV-2 variants correlates with COVID-19 severityVishal Rao, Ushashi Banerjee, Narmada Sambaturu, et al.
Journal of Chemical Information and Modeling|September 27, 2023
PathTracer Comprehensively Identifies Hypoxia-Induced Dormancy Adaptations in <i>Mycobacterium tuberculosis</i>Ushashi Banerjee, Adithya Chedere, Raksha Padaki, et al.
Genes and Immunity|July 12, 2023
Systems-level profiling of early peripheral host-response landscape variations across COVID-19 severity states in an Indian cohortUshashi Banerjee, Sneha Chunchanur, Ambica R, et al.
Molecular Omics|August 16, 2022
A 9-gene biomarker panel identifies bacterial coinfections in culture-negative COVID-19 casesUshashi Banerjee, Pragati Rao, Megha Reddy, et al.
Immunology|March 20, 2024
Inhibition of leukotriene-B4 signalling-mediated host response to tuberculosis is a potential mode of adjunctive host-directed therapyUshashi Banerjee, Salik Miskat Borbora, Madhura Guha, et al.
Ebiomedicine|April 27, 2021
VB<sub>10</sub>, a new blood biomarker for differential diagnosis and recovery monitoring of acute viral and bacterial infectionsSathyabaarathi Ravichandran, Ushashi Banerjee, Gayathri Devi Dr, et al.
Cell Reports|April 25, 2024
The MYCN 5' UTR as a therapeutic target in neuroblastomaMarina P Volegova, Lauren E Brown, Ushashi Banerjee, et al.
Science Advances|December 13, 2023
Cysteine desulfurase (IscS)-mediated fine-tuning of bioenergetics and SUF expression prevents <i>Mycobacterium tuberculosis</i> hypervirulenceMayashree Das, Sreesa Sreedharan, Somnath Shee, et al.
Pageof 1